title: Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways.
abstract: Trauma and sepsis can cause acute lung injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) in part by triggering neutrophil (PMN)-mediated increases in endothelial cell (EC) permeability. We had shown that mitochondrial (mt) damage-associated molecular patterns (DAMPs) appear in the blood after injury or shock and activate human PMN. So we now hypothesized that mitochondrial DAMPs (MTD) like mitochondrial DNA (mtDNA) and peptides might play a role in increased EC permeability during systemic inflammation and proceeded to evaluate the underlying mechanisms. MtDNA induced changes in EC permeability occurred in two phases: a brief, PMN-independent 'spike' in permeability was followed by a prolonged PMN-dependent increase in permeability. Fragmented mitochondria (MTD) caused PMN-independent increase in EC permeability that were abolished with protease treatment. Exposure to mtDNA caused PMN-EC adherence by activating expression of adherence molecule expression in both cell types. Cellular activation was manifested as an increase in PMN calcium flux and EC MAPK phosphorylation. Permeability and PMN adherence were attenuated by endosomal TLR inhibitors. EC lacked formyl peptide receptors but were nonetheless activated by mt-proteins, showing that non-formylated mt-protein DAMPs can activate EC. Mitochondrial DAMPs can be released into the circulation by many processes that cause cell injury and lead to pathologic endothelial permeability. We show here that mitochondria contain multiple DAMP motifs that can act on EC and/or PMN via multiple pathways. This can enhance PMN adherence to EC, activate PMN-EC interactions and subsequently increase systemic endothelial permeability. Mitochondrial DAMPs may be important therapeutic targets in conditions where inflammation pathologically increases endothelial permeability.
authors.affiliation: Department of Surgery, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America.
authors.forename: Shiqin
authors.initials: S
authors.lastname: Sun
authors.forename: Tolga
authors.initials: T
authors.lastname: Sursal
authors.forename: Yasaman
authors.initials: Y
authors.lastname: Adibnia
authors.forename: Cong
authors.initials: C
authors.lastname: Zhao
authors.forename: Yi
authors.initials: Y
authors.lastname: Zheng
authors.forename: Haipeng
authors.initials: H
authors.lastname: Li
authors.forename: Leo E
authors.initials: LE
authors.lastname: Otterbein
authors.forename: Carl J
authors.initials: CJ
authors.lastname: Hauser
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Itagaki
mesh_terms: D055371:Acute Lung Injury / Q000503:physiopathology*; D015153:Blotting, Western; D002448:Cell Adhesion / Q000502:physiology; D018929:Cell Culture Techniques; D002463:Cell Membrane Permeability / Q000502:physiology*; D002478:Cells, Cultured; D004272:DNA, Mitochondrial / Q000378:metabolism; D042783:Endothelial Cells / Q000502:physiology*; D006801:Humans; D018613:Microscopy, Confocal; D009504:Neutrophils / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D012128:Respiratory Distress Syndrome / Q000503:physiopathology*; D013367:Submitochondrial Particles / Q000378:metabolism* / Q000473:pathology
chemical_list: D004272:DNA, Mitochondrial